Data pharmacovigilance analysis of medroxyprogesterone-related adverse events in the FDA adverse event reporting system

Objectives Medroxyprogesterone acetate (MPA), a steroid progesterone, is widely used to treat endometriosis, menstrual disorders, and uterine bleeding in clinical practice. However, the safety profile of MPA requires comprehensive evaluation.